Po-Jung Chen

发表

Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2021, Asian journal of surgery.

Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2020, PloS one.

Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer

Jaw-Yuan Wang, Chun-Ming Huang, Ching-wen Huang, 2021, PloS one.

Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line Therapy

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Oncology research.

Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Cancer management and research.

BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF-Mutated Metastatic Colorectal Cancer—A Case Series Study Target Therapy of BRAF-Mutated mCRC

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2021, Medicina.

Impact of Previous Abdominal Surgery on Robotic-Assisted Rectal Surgery in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy: A Propensity Score Matching Study

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2020 .

Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, The Journal of international medical research.

MicroRNA-148a induces apoptosis and prevents angiogenesis with bevacizumab in colon cancer through direct inhibition of ROCK1/c-Met via HIF-1α under hypoxia

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Aging.

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2021, Cancer management and research.

CMAR_A_355318 1541..1549

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022 .

A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab

Jaw-Yuan Wang, T. Cheng, Ching-wen Huang, 2021, Oncology research.

Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review

Jaw-Yuan Wang, Ming-Yii Huang, Chun-Ming Huang, 2022, Frontiers in Oncology.

Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2020, World Journal of Surgical Oncology.

Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer

Jaw-Yuan Wang, Ching-wen Huang, H. Tsai, 2022, Cells.

Low Ligation Plus High Dissection Versus High Ligation of the Inferior Mesenteric Artery in Sigmoid Colon and Rectal Cancer Surgery: A Meta-Analysis

Jaw-Yuan Wang, H. Tsai, W. Su, 2021, Frontiers in Oncology.

An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness

Jaw-Yuan Wang, H. Tsai, W. Su, 2019, Translational cancer research.

Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting

Jaw-Yuan Wang, H. Tsai, W. Su, 2018, Translational oncology.

Comparison of Next-Generation Sequencing and Polymerase Chain Reaction for Personalized Treatment-Related Genomic Status in Patients with Metastatic Colorectal Cancer

Yun-Ru Liu, Jaw-Yuan Wang, H. Tsai, 2022, Current issues in molecular biology.

Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2022, Journal of oncology.

VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis.

M. Hou, S. Yuan, Po-Jung Chen, 2017, Cancer letters.

miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met

Jaw-Yuan Wang, Ming-Yii Huang, H. Tsai, 2021, Biomedicines.

Identifying and clinically validating biomarkers for immunotherapy in colorectal cancer

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Expert review of molecular diagnostics.

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Frontiers in Oncology.

Robotic-assisted total mesorectal excision in low-lying rectal cancer

Jaw-Yuan Wang, Ming-Yii Huang, Chun-Ming Huang, 2018, Mini-invasive Surgery.

Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Journal of oncology.

Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2021, International journal of molecular sciences.

Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2022, Frontiers in Oncology.

Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy

Jaw-Yuan Wang, H. Tsai, Yen-Cheng Chen, 2023, Oncology research.

UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI

Jaw-Yuan Wang, H. Tsai, W. Su, 2021, Journal of oncology.

Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer

Jaw-Yuan Wang, H. Tsai, W. Su, 2020, Frontiers in Oncology.

Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in BRAFV600E-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study

H. Tsai, Yen-Cheng Chen, Tsung-Kun Chang, 2023, Medicina.

Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis

H. Tsai, Yen-Cheng Chen, Y. Yeh, 2023, World Journal of Surgical Oncology.